InMed Pharmaceuticals (INM) Earnings Date, Estimates & Call Transcripts → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free INM Stock Alerts $0.28 +0.00 (+1.24%) (As of 12:11 PM ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateOct. 4EstimatedActual EPS (Feb. 13) -$0.19 Missed By -$0.19 Get InMed Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for INM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueINM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects INM Earnings Date and InformationInMed Pharmaceuticals last issued its quarterly earnings data on February 13th, 2024. The reported ($0.19) earnings per share for the quarter. The firm earned $1.24 million during the quarter. InMed Pharmaceuticals has generated $0.00 earnings per share over the last year. InMed Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 4th, 2024 based off prior year's report dates.Read More InMed Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 10/4/2024Estimated)------- 2/13/2024Q2 2024-($0.19)($0.19)($0.19)-$1.24 million11/14/2023Q1 2024-($0.76)($0.76)($0.76)-$0.90 million5/15/2023Q3 2023-($0.60)($0.60)($0.60)-$1.03 million2/17/2023Q2 2023($4.50)($0.91)+$3.59($0.91)-$0.47 million11/11/2022Q1 2023($4.25)($4.06)+$0.19($4.06)-$0.32 million9/23/2022Q4 2022($5.50)($12.92)($7.42)($12.92)$0.75 million$0.52 million Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/13/2022Q3 2022($5.75)($6.25)($0.50)($0.25)$0.43 million$0.31 million2/14/2022Q2 2022($6.00)($7.75)($1.75)($0.31)$0.25 million$0.27 million 11/10/2021Q3 2021($8.75)($6.25)+$2.50($0.25)--9/23/2021Q2 2021($8.50)($10.25)($1.75)($0.41)-- InMed Pharmaceuticals Earnings - Frequently Asked Questions When is InMed Pharmaceuticals's earnings date? InMed Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, October 4th, 2024 based off last year's report dates. Learn more on INM's earnings history. How much revenue does InMed Pharmaceuticals generate each year? InMed Pharmaceuticals (NASDAQ:INM) has a recorded annual revenue of $4.14 million. How much profit does InMed Pharmaceuticals generate each year? InMed Pharmaceuticals (NASDAQ:INM) has a recorded net income of -$7.95 million. INM has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: PaxMedica Earnings Date 180 Life Sciences Earnings Date Panbela Therapeutics Earnings Date Ayala Pharmaceuticals Earnings Date PainReform Earnings Date Bio-Path Earnings Date Qualigen Therapeutics Earnings Date NeuBase Therapeutics Earnings Date Allarity Therapeutics Earnings Date GRI Bio Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong Earnings This page (NASDAQ:INM) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden to Drop BOMBSHELL June 13th?Paradigm PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.